Inge M. Ambros

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

International neuroblastoma risk group consortium: a model of a networking for rare cancers.

International neuroblastoma risk group consortium: a model of a networking for rare cancers.

Journal: Journal of the National Cancer Institute

Published: June 22, 2025

International neuroblastoma risk group consortium: a model of networking for rare cancers.

International neuroblastoma risk group consortium: a model of networking for rare cancers.

Journal: Journal of the National Cancer Institute

Published: June 22, 2025

Sensitive detection of minimal residual disease and immunotherapy targets by multi-modal bone marrow analysis in high-risk neuroblastoma - a multi-center study.

Sensitive detection of minimal residual disease and immunotherapy targets by multi-modal bone marrow analysis in high-risk neuroblastoma - a multi-center study.

Journal: Journal of experimental & clinical cancer research : CR

Published: March 29, 2025

Human repair-related Schwann cells adopt functions of antigen-presenting cells in vitro.

Human repair-related Schwann cells adopt functions of antigen-presenting cells in vitro.

Journal: Glia

Published: February 17, 2022

Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroup.

Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroup.

Journal: Scientific reports

Published: August 20, 2021

Landscape of Bone Marrow Metastasis in Human Neuroblastoma Unraveled by Transcriptomics and Deep Multiplex Imaging.

Landscape of Bone Marrow Metastasis in Human Neuroblastoma Unraveled by Transcriptomics and Deep Multiplex Imaging.

Journal: Cancers

Published: July 22, 2021

Evaluation of Deep Learning Architectures for Complex Immunofluorescence Nuclear Image Segmentation.

Evaluation of Deep Learning Architectures for Complex Immunofluorescence Nuclear Image Segmentation.

Journal: IEEE transactions on medical imaging

Published: March 30, 2021

Comparison of three different methods to detect bone marrow involvement in patients with neuroblastoma.

Comparison of three different methods to detect bone marrow involvement in patients with neuroblastoma.

Journal: Journal of cancer research and clinical oncology

Published: December 31, 2020

Long-Term Outcome and Role of Biology within Risk-Adapted Treatment Strategies: The Austrian Neuroblastoma Trial A-NB94.

Long-Term Outcome and Role of Biology within Risk-Adapted Treatment Strategies: The Austrian Neuroblastoma Trial A-NB94.

Journal: Cancers

Published: November 23, 2020

Spatial and temporal intratumour heterogeneity has potential consequences for single biopsy-based neuroblastoma treatment decisions.

Spatial and temporal intratumour heterogeneity has potential consequences for single biopsy-based neuroblastoma treatment decisions.

Journal: Nature communications

Published: November 23, 2020

Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden.

Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden.

Journal: Nature communications

Published: November 19, 2020

Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group.

Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: September 09, 2020

Showing 1-12 of 32

Last Updated: 09/26/2026